
Biotechs with few products in the portfolio are always at a risk should results come back flat, it often leads …
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership

